rs3740392

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -12 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_Strong

The NM_020682.4(AS3MT):c.610+63T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.25 (AC=370,792) in the gnomAD database across 1,481,194 control chromosomes, including 47,616 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.313. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.25 ( 4724 hom., cov: 32)
Exomes 𝑓: 0.25 ( 42892 hom. )

Consequence

AS3MT
NM_020682.4 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.31

Publications

32 publications found
Variant links:
Genes affected
AS3MT (HGNC:17452): (arsenite methyltransferase) AS3MT catalyzes the transfer of a methyl group from S-adenosyl-L-methionine (AdoMet) to trivalent arsenical and may play a role in arsenic metabolism (Lin et al., 2002 [PubMed 11790780]).[supplied by OMIM, Mar 2008]
BORCS7-ASMT (HGNC:49183): (BORCS7-ASMT readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring C10orf32 (chromosome 10 open reading frame 32) and AS3MT (arsenic, +3 oxidation state, methyltransferase) genes. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is therefore unlikely to produce a protein product. [provided by RefSeq, Dec 2010]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_020682.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript

Our verdict: Benign. The variant received -12 points.

BP4
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Strong).
BA1
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.3131 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_020682.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AS3MT
NM_020682.4
MANE Select
c.610+63T>C
intron
N/ANP_065733.2Q9HBK9-1
BORCS7-ASMT
NR_037644.1
n.1015+63T>C
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AS3MT
ENST00000369880.8
TSL:1 MANE Select
c.610+63T>C
intron
N/AENSP00000358896.3Q9HBK9-1
BORCS7-ASMT
ENST00000299353.6
TSL:5
n.*617+63T>C
intron
N/AENSP00000299353.5Q96B45
AS3MT
ENST00000942423.1
c.595+63T>C
intron
N/AENSP00000612482.1A0ACI8U690

Frequencies

GnomAD3 genomes
AF:
0.246
AC:
37439
AN:
152114
Hom.:
4722
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.223
Gnomad AMI
AF:
0.166
Gnomad AMR
AF:
0.223
Gnomad ASJ
AF:
0.328
Gnomad EAS
AF:
0.283
Gnomad SAS
AF:
0.249
Gnomad FIN
AF:
0.216
Gnomad MID
AF:
0.307
Gnomad NFE
AF:
0.263
Gnomad OTH
AF:
0.255
GnomAD4 exome
AF:
0.251
AC:
333342
AN:
1328962
Hom.:
42892
AF XY:
0.252
AC XY:
167995
AN XY:
667908
show subpopulations
African (AFR)
AF:
0.221
AC:
6796
AN:
30726
American (AMR)
AF:
0.187
AC:
8297
AN:
44404
Ashkenazi Jewish (ASJ)
AF:
0.310
AC:
7801
AN:
25186
East Asian (EAS)
AF:
0.240
AC:
9348
AN:
39030
South Asian (SAS)
AF:
0.241
AC:
20084
AN:
83194
European-Finnish (FIN)
AF:
0.223
AC:
11498
AN:
51668
Middle Eastern (MID)
AF:
0.326
AC:
1793
AN:
5506
European-Non Finnish (NFE)
AF:
0.255
AC:
253319
AN:
993406
Other (OTH)
AF:
0.258
AC:
14406
AN:
55842
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
11894
23788
35681
47575
59469
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8048
16096
24144
32192
40240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.246
AC:
37450
AN:
152232
Hom.:
4724
Cov.:
32
AF XY:
0.244
AC XY:
18184
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.223
AC:
9278
AN:
41546
American (AMR)
AF:
0.223
AC:
3407
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.328
AC:
1140
AN:
3472
East Asian (EAS)
AF:
0.282
AC:
1463
AN:
5182
South Asian (SAS)
AF:
0.250
AC:
1206
AN:
4830
European-Finnish (FIN)
AF:
0.216
AC:
2287
AN:
10598
Middle Eastern (MID)
AF:
0.313
AC:
92
AN:
294
European-Non Finnish (NFE)
AF:
0.263
AC:
17890
AN:
67990
Other (OTH)
AF:
0.254
AC:
536
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1487
2974
4461
5948
7435
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
398
796
1194
1592
1990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.255
Hom.:
3717
Bravo
AF:
0.245
Asia WGS
AF:
0.242
AC:
840
AN:
3478

Local populations

ToMMo 61KJPN (+60KJPN MNV)
AF:
0.186
AC:
22780
AN:
122684
WBBC (Westlake BioBank for Chinese) pilot
AF:
0.309
AC:
2766
AN:
8960
Hom.:
426
ABraOM SABE-WGS-1171
AF:
0.254
AC:
594
AN:
2342
Hom.:
84

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
6.3
DANN
Benign
0.72
PhyloP100
1.3

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.